Covered recipient · General Payments record
PAOLO PIO TEMPONGKO
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2022–2024
$3,033.57
- Reported across 133 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $914.86 | 33 |
| Education | $198.99 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $539.00 | 11 |
| Amgen Inc. | $372.19 | 12 |
| ABBVIE INC. | $67.33 | 4 |
| PFIZER INC. | $46.96 | 3 |
| UCB, Inc. | $22.03 | 1 |
| Aurinia Pharma U.S., Inc. | $19.69 | 1 |
| ANI Pharmaceuticals, Inc. | $18.10 | 1 |
| Kiniksa Pharmaceuticals International, plc | $15.33 | 1 |
| GlaxoSmithKline, LLC. | $13.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.76 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106209713 | CMS |
| ABBVIE INC. | $18.41 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106209715 | CMS |
| ABBVIE INC. | $16.65 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106209717 | CMS |
| ABBVIE INC. | $17.51 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106209719 | CMS |
| Amgen Inc. | $16.17 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116173682 | CMS |
| Amgen Inc. | $5.30 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116173721 | CMS |
| Amgen Inc. | $13.30 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116173729 | CMS |
| Amgen Inc. | $15.75 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116173735 | CMS |
| Amgen Inc. | $99.81 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116173688 | CMS |
| Amgen Inc. | $15.39 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116173694 | CMS |
| Amgen Inc. | $17.28 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116173701 | CMS |
| Amgen Inc. | $16.93 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116173708 | CMS |
| Amgen Inc. | $17.01 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116173741 | CMS |
| Amgen Inc. | $121.02 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117699080 | CMS |
| Amgen Inc. | $17.87 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116173715 | CMS |
| Amgen Inc. | $16.36 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116173749 | CMS |
| ANI Pharmaceuticals, Inc. | $18.10 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091154006 | CMS |
| Aurinia Pharma U.S., Inc. | $19.69 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150693289 | CMS |
| GlaxoSmithKline, LLC. | $13.22 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116142506 | CMS |
| Janssen Biotech, Inc. | $15.63 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078344381 | CMS |
| Janssen Biotech, Inc. | $104.11 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078344414 | CMS |
| Janssen Biotech, Inc. | $99.99 | 04/19/2024 | Education | Undisputed | 01/23/2026 | 1078344377 | CMS |
| Janssen Biotech, Inc. | $13.33 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078344373 | CMS |
| Janssen Biotech, Inc. | $99.00 | 08/08/2024 | Education | Undisputed | 01/23/2026 | 1078344396 | CMS |
| Janssen Biotech, Inc. | $15.00 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078344410 | CMS |
| Janssen Biotech, Inc. | $13.70 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078344403 | CMS |
| Janssen Biotech, Inc. | $16.57 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078344389 | CMS |
| Janssen Biotech, Inc. | $141.93 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078344385 | CMS |
| Janssen Biotech, Inc. | $11.48 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078344406 | CMS |
| Janssen Biotech, Inc. | $8.26 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078344369 | CMS |
| Kiniksa Pharmaceuticals International, plc | $15.33 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154894392 | CMS |
| PFIZER INC. | $15.45 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130929709 | CMS |
| PFIZER INC. | $15.89 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130979349 | CMS |
| PFIZER INC. | $15.62 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131037422 | CMS |
| UCB, Inc. | $22.03 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143274355 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.